Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Brain Stimulation 2024 Charles R Conway, Scott T Aaronson, Harold A Sackeim et al. 16 citations
RECOVER is a randomized sham-controlled trial of vagus nerve stimulation and the largest such trial conducted with a psychiatric neuromodulation intervention. To describe pre-implantation baseline clinical characteristics and treatment history of patients with unipolar, major depressive disorder (MDD), overall and as a function of exposure to interventional psychiatric treatments (INTs),...
DOI: 10.1016/j.brs.2024.03.016 (opens in new tab)
Full text (opens in new tab)
Esketamine
Electroconvulsive therapy
Recover trial
Treatment-resistant depression trd
+7